Cargando…
Management of tubal ectopic pregnancy with methotrexate in the setting of symptomatic Coronavirus disease 2019 (COVID-19): A case report
BACKGROUND: Coronavirus Disease 2019 (COVID-19) represents a complex therapeutic challenge. As the pandemic progresses, patients are presenting with ectopic pregnancies (EPs) and symptomatic COVID-19. OBJECTIVE: We present the management of a patient with multiple medical comorbidities and tubal EP...
Autores principales: | Millan, NM, Morano, J, Florez, L, Carugno, J, Medina, CA |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Universa Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8823271/ https://www.ncbi.nlm.nih.gov/pubmed/34555882 http://dx.doi.org/10.52054/FVVO.13.3.030 |
Ejemplares similares
-
Predictors of Successful Medical Management With Methotrexate in Unruptured Tubal Ectopic Pregnancy
por: Ray, Alokananda, et al.
Publicado: (2022) -
Apoptosis versus necrosis in tubal ectopic pregnancies following Methotrexate
por: Gil, Yaron, et al.
Publicado: (2023) -
Subsequent pregnancy outcomes among women with tubal ectopic pregnancy treated with methotrexate
por: Mackenzie, Scott C, et al.
Publicado: (2023) -
Treatment success with two doses of methotrexate vs single dose of methotrexate in Ectopic Tubal Pregnancy
por: Khakwani, Mehnaz, et al.
Publicado: (2022) -
Uterine artery embolization in association with methotrexate infusion for the treatment of tubal ectopic pregnancy
por: Li, Zhi, et al.
Publicado: (2019)